Skip to main content

Table 2 Linear regression analyses for children with specialist-diagnosed food allergy, by proxies of severity (n = 59)

From: Health-related quality of life worsens by school age amongst children with food allergy

HRQL Unadjusted Model 1 Model 2
B 95% CI p value B 95% CI p value B 95% CI p value
A. Symptom severity
Overall
 Less§ Ref    Ref    Ref   
 More 0.95 0.29–1.61 0.005 0.46 − 0.13–1.05 0.12 0.51 − 0.09–1.10 0.09
FA
 Less§ Ref    Ref    Ref   
 More 0.89 0.20–1.59 0.01 0.28 0.33–0.89 0.37 0.27 − 0.36–0.89 0.39
EI
 Less§ Ref    Ref    Ref   
 More 1.01 0.34–1.67 0.004 0.55 − 0.07–1.16 0.81 0.59 − 0.03–1.22 0.06
SDL
 Less§ Ref    Ref    Ref   
 More¶ 0.96 0.13–1.78 0.02 0.48 − 0.34–1.31 0.24 0.57 − 0.25–1.39 0.17
B. EAI prescription
Overall
 No Ref    Ref    Ref   
 Yes 0.99 0.44–1.55 0.001 0.70 0.17–1.23 0.01 0.57  0.01–1.15 0.05
FA
 No Ref    Ref    Ref   
 Yes 1.22 0.62–1.81 <0.001 0.94 0.39–1.50 0.001 0.97 0.36–1.58 0.002
EI
 No Ref    Ref    Ref   
 Yes 1.04 0.44–1.63 0.001 0.68 0.13–1.24 0.02 0.55 − 0.06–1.16 0.08
SDL
 No Ref    Ref    Ref   
 Yes 0.78 0.07–1.50 0.03 0.53 − 0.21–1.28 0.16 0.29 − 0.51–1.10 0.47
C. Number of concomitant allergic disease
Overall
 0–2 Ref    Ref    Ref   
 3 0.93 0.29–1.57 0.005 0.41 − 0.13–0.95 0.13 0.42 − 0.12–0.95 0.13
FA
 0–2 Ref    Ref    Ref   
 3 0.81 0.13–1.49 0.02 0.24 − 0.32–0.79 0.40 0.23 − 0.33–0.80 0.41
EI
 0–2 Ref    Ref    Ref   
 3 0.93 0.27–1.58 0.006 0.39 − 0.18–0.95 0.17 0.39 − 0.17–0.96 0.17
SDL
 0–2 Ref    Ref    Ref   
 3 1.07 0.31–1.82 0.006 0.63 − 0.13–1.38 0.10 0.64 − 0.11–1.38 0.09
  1. 95% CI 95th percent confidence interval, EAI epinephrine autoinjector, EI emotional impact, FA food anxiety, HRQL health-related quality of life, SDL social and dietary limitations
  2. Adjusted for age, EAI prescription and number of concomitant allergic diseases
  3. Adjusted for age, EAI prescription, number of concomitant allergic diseases and region
  4. §Less severe symptoms: skin, oral, gastroenteritis and/or rhinoconjunctivitis
  5. More severe symptoms: respiratory and/or cardiovascular